Postdoc: Structure-Based Drug Design & MD Simulations

ISTITUTO ITALIANO DI TECNOLOGIA; Italia; In loco; EUR 30.000 - 37.000; Tempo pieno

Vantaggi offerti da questo lavoro

Private health care coverage

Tax deduction up to 90%

Descrizione del lavoro

ISTITUTO ITALIANO DI TECNOLOGIA seeks a researcher to perform molecular modelling and simulations of small molecule drugs in a multinational environment. You will collaborate with computational and experimental researchers in medicinal chemistry and pharmacology.

The role focuses on structure-based drug design using docking, MD, and ML methods, with a target on anticancer drug discovery. A 1-year renewable contract is offered, with an open, inclusive research setting.

Competenze

• PhD in Chemistry, Physics or related disciplines.
• Experience on simulations and/or machine learning, and computer-aided drug design.
• Programming and scripting abilities are highly desirable.
• Strong publications record in ML and/or computational chemistry.
• Good command of English; ability to coach junior scientists.

Mansioni

• Molecular modelling and simulations of small molecule drugs and complexes.
• Compute MD, docking, FEP and enhanced sampling with ML support.
• Write research papers and open-source software to reproduce results.
• Present and share work with the team.

Conoscenze

Programming

Machine learning

Drug design

Molecular modeling

Simulation software

Formazione

PhD in Chemistry, Physics or related disciplines

Strumenti

TensorFlow

Molecular docking

Molecular dynamics

Descrizione del lavoro

ISTITUTO ITALIANO DI TECNOLOGIA seeks a researcher to perform molecular modelling and simulations of small molecule drugs in a multinational environment. You will collaborate with computational and experimental researchers in medicinal chemistry and pharmacology.

The role focuses on structure-based drug design using docking, MD, and ML methods, with a target on anticancer drug discovery. A 1-year renewable contract is offered, with an open, inclusive research setting.